{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T05:37:57Z","timestamp":1794980277120,"version":"4.9.1"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:p>The CD4\/CD8 ratio is a pivotal metric in assessing the status of the immune system, crucially implicated in human immunodeficiency virus (HIV) infection dynamics. This review elucidates the multifaceted roles of CD4 and CD8 T cells in immune surveillance and response orchestration. We explore the intricate mechanisms governing their equilibrium and the consequential impact on immune homeostasis. Moreover, we dissect how HIV undermines this delicate balance, precipitating a cascade of immune dysregulation culminating in AIDS progression. Insights into the CD4\/CD8 ratio\u2019s prognostic value for disease trajectory and treatment efficacy are discussed, highlighting its potential as a pivotal biomarker in clinical management. Additionally, it interrogates emerging therapeutic modalities leveraging the manipulation of CD4\/CD8 ratios as a strategic avenue for HIV intervention. Immunomodulatory agents and gene-based approaches aimed at restoring immune balance hold promise in bolstering host defenses against HIV. By harnessing a deeper understanding of the interplay between CD4 and CD8 T cells, novel therapeutic strategies seek to fortify the immune landscape against HIV-induced immunopathogenesis. This review underscores the significance of CD4\/CD8 ratios as not only diagnostic indicators but also as potential targets for therapeutic intervention, heralding new horizons in the battle against HIV\/AIDS.<\/jats:p>","DOI":"10.1097\/md.0000000000047396","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T17:02:04Z","timestamp":1769965324000},"page":"e47396","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["CD4\/CD8 ratios as immune architects \u2013 building defenses against HIV: A narrative review"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4538-0161","authenticated-orcid":false,"given":"Emmanuel Ifeanyi","family":"Obeagu","sequence":"first","affiliation":[{"name":"Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimbabwe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getrude Uzoma","family":"Obeagu","sequence":"additional","affiliation":[{"name":"School of Nursing Science, Kampala International University, Ishaka, Uganda."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"e1775","DOI":"10.1002\/hsr2.1775","article-title":"Infectious diseases in Afghanistan: strategies for health system improvement.","volume":"6","author":"Essar","year":"2023","journal-title":"Health Sci Rep"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/pharmaceutics12070663","article-title":"Harnessing the complete repertoire of conventional dendritic cell functions for cancer immunotherapy.","volume":"12","author":"Amon","year":"2020","journal-title":"Pharmaceutics"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41590-022-01342-8","article-title":"Maladaptive consequences of inflammatory events shape individual immune identity.","volume":"23","author":"Halper-Stromberg","year":"2022","journal-title":"Nat Immunol"},{"key":"R4-20260519","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/j.immuni.2021.06.006","article-title":"The neutrophil.","volume":"54","author":"Burn","year":"2021","journal-title":"Immunity"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"eabj9842","DOI":"10.1126\/scisignal.abj9842","article-title":"The perception and response of T cells to a changing environment are based on the law of initial value.","volume":"15","author":"Huseby","year":"2022","journal-title":"Sci Signaling"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"e1006618","DOI":"10.1371\/journal.ppat.1006618","article-title":"The immune battlefield: the impact of inflammatory cytokines on CD8+ T-cell immunity.","volume":"13","author":"Condotta","year":"2017","journal-title":"PLoS Pathog"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4+ T cells in CD8+ T cell memory.","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1128\/CMR.00014-10","article-title":"The airway epithelium: soldier in the fight against respiratory viruses.","volume":"24","author":"Vareille","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3389\/fimmu.2017.01215","article-title":"Coinhibitory receptor expression and immune checkpoint blockade: maintaining a balance in CD8+ T cell responses to chronic viral infections and cancer.","volume":"8","author":"Okoye","year":"2017","journal-title":"Front Immunol"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"e20201730","DOI":"10.1084\/jem.20201730","article-title":"The architectural design of CD8+ T cell responses in acute and chronic infection: parallel structures with divergent fates.","volume":"218","author":"Chung","year":"2021","journal-title":"J Exp Med"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"E2905","DOI":"10.1073\/pnas.1304859110","article-title":"Asymmetric thymocyte death underlies the CD4: CD8 T-cell ratio in the adaptive immune system.","volume":"110","author":"Sinclair","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/ijms22020523","article-title":"Role of CD4+ T cells in the control of viral infections: recent advances and open questions.","volume":"22","author":"Kervevan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","article-title":"Revisiting the role of CD4+ T cells in cancer immunotherapy\u2014new insights into old paradigms.","volume":"28","author":"Tay","year":"2021","journal-title":"Cancer Gene Ther"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"669474","DOI":"10.3389\/fimmu.2021.669474","article-title":"Differentiation and regulation of TH cells: a balancing act for cancer immunotherapy.","volume":"12","author":"Basu","year":"2021","journal-title":"Front Immunol"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11307-021-01652-7","article-title":"ImmunoPET: harnessing antibodies for imaging immune cells.","volume":"24","author":"Wu","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00018-016-2135-z","article-title":"Immune responses in multiple myeloma: role of the natural immune surveillance and potential of immunotherapies.","volume":"73","author":"Guillerey","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/PSY.0000000000001129","article-title":"Individual differences in CD4\/CD8 T-cell ratio trajectories and associated risk profiles modeled from acute HIV infection.","volume":"84","author":"Paul","year":"2022","journal-title":"Psychosom Med"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","article-title":"CD8+ CD28\u2212 and CD8+ CD57+ T cells and their role in health and disease.","volume":"134","author":"Strioga","year":"2011","journal-title":"Immunology"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1093\/jac\/dkv036","article-title":"Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.","volume":"70","author":"Bastard","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"R22-20260519","doi-asserted-by":"crossref","first-page":"908697","DOI":"10.3389\/fimmu.2022.908697","article-title":"Functional restoration of exhausted CD8 T cells in chronic HIV-1 infection by targeting mitochondrial dysfunction.","volume":"13","author":"Alrubayyi","year":"2022","journal-title":"Front Immunol"},{"key":"R23-20260519","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3389\/fimmu.2020.01223","article-title":"The role of immunomodulatory receptors in the pathogenesis of HIV infection: a therapeutic opportunity for HIV cure?","volume":"11","author":"Chen","year":"2020","journal-title":"Front Immunol"},{"key":"R24-20260519","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41576-020-00297-6","article-title":"Host genetics and infectious disease: new tools, insights and translational opportunities.","volume":"22","author":"Kwok","year":"2021","journal-title":"Nat Rev Genet"},{"key":"R25-20260519","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.sbi.2013.03.007","article-title":"HIV-1 envelope glycoprotein structure.","volume":"23","author":"Merk","year":"2013","journal-title":"Curr Opin Struct Biol"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-9-S1-S1","article-title":"Conformational HIV-1 envelope on particulate structures: a tool for chemokine coreceptor binding studies.","volume":"9","author":"Tagliamonte","year":"2011","journal-title":"J Transl Med"},{"key":"R27-20260519","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.24.021605.090557","article-title":"GP120: target for neutralizing HIV-1 antibodies.","volume":"24","author":"Pantophlet","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ejmech.2011.01.046","article-title":"Viral surface glycoproteins, gp120 and gp41, as potential drug targets against HIV-1: brief overview one quarter of a century past the approval of zidovudine, the first anti-retroviral drug.","volume":"46","author":"Teixeira","year":"2011","journal-title":"Eur J Med Chem"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.biochi.2014.08.015","article-title":"Membrane organization of virus and target cell plays a role in HIV entry.","volume":"107 Pt A","author":"Dumas","year":"2014","journal-title":"Biochimie"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","article-title":"Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections?","volume":"8","author":"Crux","year":"2017","journal-title":"Front Immunol"},{"key":"R31-20260519","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","article-title":"The influence of HLA genotype on AIDS.","volume":"54","author":"Carrington","year":"2003","journal-title":"Annu Rev Med"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-4690-5-112","article-title":"Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.","volume":"5","author":"Dyer","year":"2008","journal-title":"Retrovirology"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"e1004078","DOI":"10.1371\/journal.ppat.1004078","article-title":"HIV-infected individuals with low CD4\/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality.","volume":"10","author":"Serrano-Villar","year":"2014","journal-title":"PLoS Pathog"},{"key":"R34-20260519","doi-asserted-by":"crossref","first-page":"111086","DOI":"10.1016\/j.humimm.2024.111086","article-title":"Genetic variants of IL-10 promoter influence susceptibility to HIV-1 infection and disease progression in the Polish population: IL-10 polymorphisms and HIV-1.","volume":"85","author":"Bratosiewicz-W\u0105sik","year":"2024","journal-title":"Hum Immunol"},{"key":"R35-20260519","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fimmu.2014.00681","article-title":"CD4 T cells mediate both positive and negative regulation of the immune response to HIV infection: complex role of T follicular helper cells and regulatory T cells in pathogenesis.","volume":"5","author":"Phetsouphanh","year":"2015","journal-title":"Front Immunol"},{"key":"R36-20260519","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1097\/QAD.0000000000000213","article-title":"Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.","volume":"28","author":"Tanaskovic","year":"2014","journal-title":"AIDS"},{"key":"R37-20260519","doi-asserted-by":"crossref","first-page":"7802","DOI":"10.4049\/jimmunol.177.11.7802","article-title":"Generation and growth of CD28nullCD8+ memory T cells mediated by IL-15 and its induced cytokines.","volume":"177","author":"Chiu","year":"2006","journal-title":"J Immunol"},{"key":"R38-20260519","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI85996","article-title":"IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.","volume":"126","author":"Younes","year":"2016","journal-title":"J Clin Invest"},{"key":"R39-20260519","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/iid3.160","article-title":"Probiotic supplementation promotes a reduction in T\u2010cell activation, an increase in Th17 frequencies, and a recovery of intestinal epithelium integrity and mitochondrial morphology in ART\u2010treated HIV\u20101\u2010positive patients.","volume":"5","author":"d\u2019Ettorre","year":"2017","journal-title":"Immun Inflammation Dis"},{"key":"R40-20260519","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1038\/s41598-022-06532-w","article-title":"Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression.","volume":"12","author":"Ngcobo","year":"2022","journal-title":"Sci Rep"},{"key":"R41-20260519","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1099\/0022-1317-81-6-1413","article-title":"Cellular receptors for viruses: links to tropism and pathogenesis.","volume":"81","author":"Schneider-Schaulies","year":"2000","journal-title":"J Gen Virol"},{"key":"R42-20260519","first-page":"2022","article-title":"Host genetic variants regulates CCR5 expression on immune cells: a study in people living with HIV and healthy controls.","volume":"2022","author":"dos Santos","year":"2022","journal-title":"bioRxiv"},{"key":"R43-20260519","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.tim.2020.03.015","article-title":"Chronic immune activation in TB\/HIV co-infection.","volume":"28","author":"Sharan","year":"2020","journal-title":"Trends Microbiol"},{"key":"R44-20260519","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/mi.2016.116","article-title":"The loss of CCR6+ and CD161+ CD4+ T-cell homeostasis contributes to disease progression in SIV-infected rhesus macaques.","volume":"10","author":"McGary","year":"2017","journal-title":"Mucosal Immunol"},{"key":"R45-20260519","first-page":"55","article-title":"Alveolar granulocytic sarcoma of the mandible in a patient with HIV.","volume":"34","author":"Colovi\u0107","year":"2011","journal-title":"Onkologie"},{"key":"R46-20260519","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3390\/cells12111496","article-title":"Special issue \u201cNew developments in natural killer cells for immunotherapy\u201d.","volume":"12","author":"Zimmer","year":"2023","journal-title":"Cells"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:02:59Z","timestamp":1779195779000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000047396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000047396","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"2024-02-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}